Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Circulating MicroRNA as Biomarker of Cardiotoxicity in Breast Cancer

This study has been completed.
Sponsor:
Collaborator:
Pomeranian Medical University Szczecin
Information provided by (Responsible Party):
Bartosz Dąbek, West Pomeranian Cancer Center
ClinicalTrials.gov Identifier:
NCT02065908
First received: February 15, 2014
Last updated: December 7, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2016
  Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)